Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway
Articolo
Data di Pubblicazione:
2012
Citazione:
Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway / V. Castiglioni, M. Onorati, C. Rochon, E. Cattaneo. - In: NEUROBIOLOGY OF DISEASE. - ISSN 0969-9961. - 46:1(2012 Apr), pp. 30-40. [10.1016/j.nbd.2011.12.032]
Abstract:
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an excessive expansion of a CAG trinucleotide repeat in the gene encoding the protein huntingtin, resulting in an elongated stretch of glutamines near the N-terminus of the protein. Here we report the derivation of a collection of 11 induced pluripotent stem (iPS) cell lines generated through somatic reprogramming of fibroblasts obtained from the R6/2 transgenic HD mouse line. We show that CAG expansion has no effect on reprogramming efficiency, cell proliferation rate, brain-derived neurotrophic factor level, or neurogenic potential. However, genes involved in the cholesterol biosynthesis pathway, which is altered in HD, are also affected in HD-iPS cell lines. Furthermore, we found a lysosomal gene upregulation and an increase in lysosome number in HD-iPS cell lines. These observations suggest that iPS cells from HD mice replicate some but not all of the molecular phenotypes typically observed in the disease; additionally, they do not manifest increased cell death propensity either under self-renewal or differentiated conditions. More studies will be necessary to transform a revolutionary technology into a powerful platform for drug screening approaches.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Induced pluripotent stem cells; Huntington's disease; Neuronal differentiation; R6/2
Elenco autori:
V. Castiglioni, M. Onorati, C. Rochon, E. Cattaneo
Link alla scheda completa: